Pro-inflammatory serum cytokines including IL-6 and IL-17 are elevated in patients after with schizophrenia pharmacological treatment (15), and have been shown to be deregulated in treatment-resistant schizophrenia (16, 17). This evidence concerns the gene IL17A and schizophrenia.